Blood and tissue sampling

PROCEDURE3 trials

Sponsors

University Hospital, Ghent, Abramson Cancer Center at Penn Medicine, Institut du Cancer de Montpellier - Val d'Aurelle

Conditions

Breast CancerBronchial CancerCardiopulmonary BypassLung Cancer

Phase 1

BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

Active, not recruitingNCT04454528

Abramson Cancer Center at Penn MedicineBreast Cancer

Start: 2020-12-07End: 2027-08-01Target: 27Updated: 2026-03-10

Unknown Phase

Cefazolin Dosing in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

CompletedNCT02749981

University Hospital, GhentCardiopulmonary Bypass

Start: 2012-12-31End: 2016-10-31Updated: 2023-05-18

Development of Clinical and Biological Database on Bronchial Cancer

Not yet recruitingNCT07085429

Institut du Cancer de Montpellier - Val d'AurelleBronchial Cancer, Lung Cancer

Start: 2025-09-30End: 2040-09-30Target: 750Updated: 2025-07-25

Related Papers

Preoperative combination radiotherapy (RT) and immune checkpoint inhibitor (ICI) in early-stage breast cancer: Influence of RT and ICI treatment sequencing (NCT04454528 post-hoc analysis).

Journal of Clinical Oncology2026-05-27

Abstract PS4-07-15: A single preoperative pembrolizumab dose plus a single subablative radiotherapy fraction (7 Gy) elicits anti-tumor immune response and increases stromal tumor infiltrating lymphocytes in triple negative breast cancer: a phase 1b/2 study

Clinical Cancer Research2026-02-17

644 Major pathologic response after a single radiotherapy fraction + a single pembrolizumab dose given preoperatively in patients with cT1N0 triple negative breast cancer (TNBC) – preliminary results of a phase 1b/2 study (NCT04454528)

Regular and Young Investigator Award Abstracts2022-11-012 citations

Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.

2017-03-0136 citations